Clopidogrel resistance and its relevance: Current concepts
Clopidogrel is the most widely used P2Y12 receptor inhibitor (P2Y12i) as a part of dual antiplatelet therapy along with aspirin. Clopidogrel is a pro-drug and is metabolized to its active metabolite by the hepatic enzyme cytochrome P4502C19 (CYP2C19). This active metabolite is responsible for the an...
Asıl Yazarlar: | , , , |
---|---|
Materyal Türü: | Makale |
Dil: | English |
Baskı/Yayın Bilgisi: |
Wolters Kluwer Medknow Publications
2024-06-01
|
Seri Bilgileri: | Journal of Family Medicine and Primary Care |
Konular: | |
Online Erişim: | https://journals.lww.com/10.4103/jfmpc.jfmpc_1473_23 |